GlassScriptPhysician profile
Nathan Stephen Gill
NPI 1194920389
$3,165.13
in general payments reported to CMS, 2019-2025
15 companies · $687 in 2025
The $687 reported for 2025 was more than what 94% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $65.37 · 2021: $470 · 2022: $820 · 2023: $385 · 2024: $514 · 2025: $687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,586.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,674.79 | 2019-2025 | Puraply, Affinity, Nushield |
| Kerecis Limited | $161.66 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Urgo Medical North America, LLC | $66.72 | 2023-2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Convatec INC. | $42.41 | 2021-2025 | |
| Lifenet Health | $31.37 | 2023 | |
| Smith+Nephew, INC. | $26.56 | 2019-2025 | Collagenase Santyl |
| Hydrofera LLC | $25.44 | 2025 | Hydrofera Blue |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.53 | 2021 | |
| Kci USA, INC. | $19.95 | 2023 | 3m Coban, Kerramax Care |
| Abbvie INC. | $19.74 | 2024 | |
| Averitas Pharma INC. | $18.39 | 2025 | Qutenza |
| Reprise Biomedical, INC. | $16.71 | 2024 | Miro3d |
| Advanced Oxygen Therapy INC. | $15.32 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.38 | 2023 | Xarelto |
| Melinta Therapeutics, LLC | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.